Gene · 220
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Two novel variants in ALDH1A3 associated with anophthalmia and congenital cystic eye. | Ophthalmic Genet | 2025 | 39746838 | PubTator, text mining | PubMed |
| Integrated Analysis of Serum and Tissue microRNA Transcriptome for Biomarker Discovery in Gastric Cancer. | Environ Toxicol | 2025 | 39400980 | PubTator, text mining | PubMed |
| Identification and Verification of Potential Markers Related to Myocardial Fibrosis by Bioinformatics Analysis. | Biochem Genet | 2025 | 39387979 | PubTator, text mining | PubMed |
| Disulfiram-Copper Potentiates Anticancer Efficacy of Standard Chemotherapy Drugs in Bladder Cancer Animal Model through ROS-Autophagy-Ferroptosis Signalling Cascade. | Curr Cancer Drug Targets | 2025 | 39323342 | PubTator, text mining | PubMed |
| β-Cell Dedifferentiation in HOMA-βlow and HOMA-βhigh Subjects. | J Clin Endocrinol Metab | 2025 | 39133811 | PubTator, text mining | PubMed |
| ALDH Enzymes and Hematological Diseases: A Scoping Review of Literature. | Discov Med | 2024 | 39726306 | PubTator, text mining | PubMed |
| Oncogene activated human breast luminal progenitors contribute basally located myoepithelial cells. | Breast Cancer Res | 2024 | 39695857 | PubTator, text mining | PubMed |
| Editorial: Pancreatic beta-cell dedifferentiation. | Front Endocrinol (Lausanne) | 2024 | 39678191 | PubTator, text mining | PubMed |
| Epithelial-mesenchymal crosstalk: the scriptwriter of craniofacial morphogenesis. | Front Cell Dev Biol | 2024 | 39583201 | PubTator, text mining | PubMed |
Expression of cancer stem cell markers (CD24, CD44 & ALDH1A3 isoform) in Breast Cancer in Indian population considering clinicopathological characteristics and response to neoadjuvant chemotherapy - a prospective analysis from a university hospital. | Indian J Surg Oncol | 2024 | 39555365 | PubTator, text mining | PubMed |
| ALDH1A3-acetaldehyde metabolism potentiates transcriptional heterogeneity in melanoma. | Cell Rep | 2024 | 39546399 | PubTator, text mining | PubMed |
| scDOT: optimal transport for mapping senescent cells in spatial transcriptomics. | Genome Biol | 2024 | 39516853 | PubTator, text mining | PubMed |
| Computational investigations of flavonoids as ALDH isoform inhibitors for treatment of cancer. | SAR QSAR Environ Res | 2024 | 39503629 | PubTator, text mining | PubMed |
| Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice. | J Diabetes Investig | 2024 | 39305123 | PubTator, text mining | PubMed |
| Retraction: MIR600HG suppresses metastasis and enhances oxaliplatin chemosensitivity by targeting ALDH1A3 in colorectal cancer. | Biosci Rep | 2024 | 39254595 | PubTator, text mining | PubMed |
| ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy. | Life Sci | 2024 | 39222837 | PubTator, text mining | PubMed |
| Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma. | Cell Metab | 2024 | 39111285 | PubTator, text mining | PubMed |
| Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation. | Mol Cancer Res | 2024 | 39083088 | PubTator, text mining | PubMed |
| Circular RNA LMBR1 inhibits bladder cancer progression by enhancing expression of the protein ALDH1A3. | Noncoding RNA Res | 2024 | 39036604 | PubTator, text mining | PubMed |
| Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALDH1‑positive pancreatic cancer stem cells. | Oncol Lett | 2024 | 39021737 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/220/papers?page=5